Related Experiment Video
Updated: Nov 28, 2025
14:58
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
10.0K
Treatment Modalities for Cherry Angiomas: A Systematic Review
Natalie Buslach1, Delila P Foulad2, Nazanin Saedi3
1Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois.
Summary
Effective treatments for cherry angiomas, including laser and non-laser therapies, are available. While pulsed dye laser (PDL) offers reduced pain, no single treatment is definitively superior for these common vascular lesions.
Area of Science:
- Dermatology
- Vascular Lesions
- Aesthetic Medicine
Background:
- Cherry angiomas are common, benign vascular growths linked to aging.
- Currently, no universally accepted primary treatment exists for these skin lesions.
Purpose of the Study:
- To systematically review evidence-based therapeutic options for cherry angiomas.
- To evaluate the efficacy and comparative outcomes of various treatment modalities.
Main Methods:
- A comprehensive literature search was conducted in May 2019 using PubMed and Cochrane Library.
- Keywords included "cherry angioma," "senile hemangioma," and "Campbell de Morgan spots."
- Ten studies were included in this systematic review.
Main Results:
- Both laser and non-laser therapies demonstrated efficacy in treating cherry angiomas.
- Pulsed dye laser (PDL) was favored for lower pain, while Nd:YAG laser showed fewer pigmentary issues.
- Non-laser options included cryotherapy, sclerotherapy, electrosurgery, and radiofrequency ablation.
Conclusions:
- Multiple therapeutic approaches effectively treat cherry angiomas, including light-based and non-light-based methods.
- A lack of high-quality comparative studies limits definitive conclusions on treatment superiority.
- Further research is needed to establish optimal treatment strategies for cherry angiomas.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
131
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
131
01:26Atherosclerosis III: Management
197
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
197
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
84
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
84
01:27Open Angle Glaucoma: Treatment
840
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
840
01:26Angina IV: Management
139
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
139
01:10Mechanism of Angiogenesis
6.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K